Biotron Ltd (BIT):企業の財務・戦略的SWOT分析

◆英語タイトル:Biotron Ltd (BIT) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0315
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Biotron Ltd (BIT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotron Ltd (Biotron) is a clinical stage biotechnology company which researches, develops and commercializes small molecules for the treatment of infectious diseases. Biotron’s core focus is to design and develop drugs that target viral ion channel proteins (viroporins). The company’s lead drug candidate, BIT225 is in Phase II clinical trials for the treatment of both HIV-1 and Hepatitis C virus (HCV). Biotron also has other preclinical programs targeting infectious diseases such as dengue, Zika and Hepatits B. The company also has discovery antiviral programs. It holds patents for drug candidates in various countries including Australia, Canada, China, Europe, Japan, New Zealand and the US. Biotron is headquartered in New South Wales, Australia.

Biotron Ltd Key Recent Developments

Nov 22,2018: Biotron : Change of principal place of business
Nov 20,2018: Biotron: Re-appointment of a director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Biotron Ltd – Key Facts
Biotron Ltd – Key Employees
Biotron Ltd – Key Employee Biographies
Biotron Ltd – Major Products and Services
Biotron Ltd – History
Biotron Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Biotron Ltd – Business Description
Biotron Ltd – Corporate Strategy
Biotron Ltd – SWOT Analysis
SWOT Analysis – Overview
Biotron Ltd – Strengths
Biotron Ltd – Weaknesses
Biotron Ltd – Opportunities
Biotron Ltd – Threats
Biotron Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Biotron Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 22, 2018: Biotron : Change of principal place of business
Nov 20, 2018: Biotron: Re-appointment of a director
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Biotron Ltd, Key Facts
Biotron Ltd, Key Employees
Biotron Ltd, Key Employee Biographies
Biotron Ltd, Major Products and Services
Biotron Ltd, History
Biotron Ltd, Other Locations
Biotron Ltd, Key Competitors
Biotron Ltd, Ratios based on current share price
Biotron Ltd, Annual Ratios
Biotron Ltd, Annual Ratios (Cont...1)
Biotron Ltd, Interim Ratios
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Biotron Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Biotron Ltd, Performance Chart (2015 - 2019)
Biotron Ltd, Ratio Charts
Biotron Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Biotron Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Biotron Ltd (BIT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stellar Biotechnologies Inc (SBOT)-製薬・医療分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Urban Outfitters Inc:戦略・SWOT・企業財務分析
    Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Specialised Therapeutics Australia Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes medicines in various therapeutic areas. The company’s products include abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline products comprise anam …
  • Vestas Wind Systems AS (VWS)-エネルギー分野:企業M&A・提携分析
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • Unchained Labs:製薬・医療:M&Aディール及び事業提携情報
    Summary Unchained Labs (Unchained) is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparati …
  • Cantel Medical Corp. (CMD)-医療機器分野:企業M&A・提携分析
    Summary Cantel Medical Corp. (Cantel) is a manufacturer and distributor of infection prevention and control products and services to the healthcare market. The company’s product portfolio includes water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reproc …
  • Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報
    Summary Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerativ …
  • U.P. Hotels Ltd.:戦略・SWOT・企業財務分析
    U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Shimadzu Corp (7701):企業の財務・戦略的SWOT分析
    Shimadzu Corp (7701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Worthington Industries Inc:企業のM&A・事業提携・投資動向
    Worthington Industries Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Worthington Industries Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Arkansas Electric Cooperative Corporation:企業の戦略的SWOT分析
    Arkansas Electric Cooperative Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Philogen SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Philogen SpA (Philogen) is a biotechnology company that develops biopharmaceuticals for the treatment of angiogenesis-related disorders. The company provides pipeline products such as darleukin, teleukin, fibromun, radretumab, dekavil and tetravil, among others. It offers technologies such a …
  • Edesa Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Edesa Biotech Inc (Edesa Biotech) is clinical-stage pharmaceutical company that endeavors to develop late stage prescription drugs for dermatological and anorectal indications. It strives to develop safe and effective alternatives to steroids. The company’s product pipeline includes EB01, a …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務分析
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tech Mahindra Limited:企業の戦略・SWOT・財務情報
    Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Garanti Technology:企業の戦略・SWOT・財務情報
    Garanti Technology - Strategy, SWOT and Corporate Finance Report Summary Garanti Technology - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Questerre Energy Corp (QEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Aegerion Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aegerion Pharmaceuticals Inc (Aegerion) is a pharmaceutical company that develops therapies for patients with debilitating often fatal and rare diseases. The company provides therapeutics to treat severe inherited lipid disorders. Its therapeutic focus comprise homozygous familial hyperchole …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆